Moderna Financial Statements (MRNA)
|
|
|
|
Report date
|
|
|
25.02.2022 |
24.02.2023 |
23.02.2024 |
21.02.2025 |
20.02.2026 |
|
01.05.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
17 736 |
18 875 |
6 848 |
3 199 |
1 944 |
|
2 225 |
|
Operating Income, bln rub |
|
|
13 296 |
9 420 |
-4 239 |
-3 945 |
-3 074 |
|
-3 412 |
|
EBITDA, bln rub |
? |
|
13 528 |
9 768 |
-3 283 |
-3 394 |
-2 553 |
|
-2 956 |
|
Net profit, bln rub |
? |
|
12 202 |
8 362 |
-4 714 |
-3 561 |
-2 822 |
|
-3 194 |
|
|
OCF, bln rub |
? |
|
13 620 |
4 981 |
-3 118 |
-3 004 |
-1 873 |
|
-1 445 |
|
CAPEX, bln rub |
? |
|
284.0 |
400.0 |
707.0 |
1 051 |
192.0 |
|
137.0 |
|
FCF, bln rub |
? |
|
13 336 |
4 581 |
-3 825 |
-4 055 |
-2 065 |
|
-1 582 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
|
|
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
OPEX, bln rub |
|
|
1 823 |
4 039 |
6 394 |
5 680 |
4 150 |
|
3 103 |
|
Cost of production, bln rub |
|
|
2 617 |
5 416 |
4 693 |
1 464 |
868.0 |
|
2 534 |
|
R&D, bln rub |
|
|
1 991 |
3 295 |
4 845 |
4 543 |
3 132 |
|
2 925 |
|
Interest expenses, bln rub |
|
|
18.0 |
29.0 |
38.0 |
24.0 |
0.000 |
|
18.0 |
|
|
Assets, bln rub |
|
|
24 669 |
25 858 |
18 426 |
14 142 |
12 338 |
|
11 488 |
|
Net Assets, bln rub |
? |
|
14 145 |
19 123 |
13 854 |
10 901 |
8 650 |
|
7 408 |
|
Debt, bln rub |
|
|
916.0 |
1 200 |
1 243 |
747.0 |
1 916 |
|
1 298 |
|
Cash, bln rub |
|
|
10 727 |
9 902 |
8 604 |
7 025 |
5 799 |
|
5 205 |
|
Net debt, bln rub |
|
|
-9 811 |
-8 702 |
-7 361 |
-6 278 |
-3 883 |
|
-3 907 |
|
|
Ordinary share price, rub |
|
|
254.0 |
|
|
41.6 |
29.5 |
|
46.9 |
|
Number of ordinary shares, mln |
|
|
403.0 |
394.0 |
382.0 |
384.0 |
389.0 |
|
395.0 |
|
|
Market cap, bln rub |
|
|
102 354 |
0 |
0 |
15 967 |
11 472 |
|
18 518 |
|
EV, bln rub |
? |
|
92 543 |
-8 702 |
-7 361 |
9 689 |
7 589 |
|
14 611 |
|
Book value, bln rub |
|
|
14 145 |
19 123 |
13 758 |
10 809 |
8 650 |
|
7 240 |
|
|
EPS, rub |
? |
|
30.3 |
21.2 |
-12.3 |
-9.27 |
-7.25 |
|
-8.09 |
|
FCF/share, rub |
|
|
33.1 |
11.6 |
-10.0 |
-10.6 |
-5.31 |
|
-4.01 |
|
BV/share, rub |
|
|
35.1 |
48.5 |
36.0 |
28.1 |
22.2 |
|
18.3 |
|
|
EBITDA margin, % |
? |
|
76.3% |
51.8% |
-47.9% |
-106.1% |
-131.3% |
|
-132.9% |
|
Net margin, % |
? |
|
68.8% |
44.3% |
-68.8% |
-111.3% |
-145.2% |
|
-143.6% |
|
FCF yield, % |
? |
|
13.0% |
|
|
-25.4% |
-18.0% |
|
-8.54% |
|
ROE, % |
? |
|
86.3% |
43.7% |
-34.0% |
-32.7% |
-32.6% |
|
-43.1% |
|
ROA, % |
? |
|
49.5% |
32.3% |
-25.6% |
-25.2% |
-22.9% |
|
-27.8% |
|
|
P/E |
? |
|
8.39 |
0.00 |
0.00 |
-4.48 |
-4.07 |
|
-5.80 |
|
P/FCF |
|
|
7.68 |
0.00 |
0.00 |
-3.94 |
-5.56 |
|
-11.7 |
|
P/S |
? |
|
5.77 |
0.00 |
0.00 |
4.99 |
5.90 |
|
8.32 |
|
P/BV |
? |
|
7.24 |
0.00 |
0.00 |
1.48 |
1.33 |
|
2.56 |
|
EV/EBITDA |
? |
|
6.84 |
-0.89 |
2.24 |
-2.85 |
-2.97 |
|
-4.94 |
|
Debt/EBITDA |
|
|
-0.73 |
-0.89 |
2.24 |
1.85 |
1.52 |
|
1.32 |
|
|
R&D/CAPEX, % |
|
|
701.1% |
823.8% |
685.3% |
432.3% |
1 631% |
|
2 135% |
|
|
CAPEX/Revenue, % |
|
|
1.60% |
2.12% |
10.3% |
32.9% |
9.88% |
|
6.16% |
|
| Moderna shareholders |
